NEWS & INSIGHTS
News & Insights
Latest industry trends and NewsPicks commentary
Industry Monthly
A monthly digest of pharmaceutical policy, market, and technology, based on public sources.
NewsPicks Insights
Healthcare commentary shared by CEO Masaya Yamamoto on NewsPicks.
Platform
Filter by Tag
ナルコレプシー新薬 ― 対症療法から病態介入へ
Takeda's narcolepsy drug ovepolexton marks a shift from symptom relief to intervening in the disease mechanism itself, replenishing deficient orexin-2 receptor signaling. It could restore not just wakefulness but overall daily functioning — but long-term safety, pricing, and access in Japan will be the key questions after approval.
膵臓がん新薬とスペシャリティ医薬品のアクセス
A new RAS/KRAS-targeted drug extended median overall survival in pancreatic cancer from 6.7 to 13.2 months. A major step in a long 'undruggable' area — but approval, pricing, and patient access in Japan will now be the focus.
フライドポテトと糖尿病リスク ― 食べ方の問題
The issue isn't the potato but the way it's eaten as fries. A BMJ study found three servings of fries a week raised type-2 diabetes risk by 20%, while boiling, baking, or mashing showed no significant rise. For prevention, 'swapping' is more realistic than 'banning'.
精神疾患11億人 ― 医療を超えた社会課題
Mental illness now affects roughly 1.17 billion people worldwide — no longer an individual issue but a matter of social infrastructure. It calls for early detection and a system spanning access, continued care, and return-to-work support.
口臭は予防医療の入口
Bad breath is often framed as a matter of cleanliness, but it is also a health signal tied to gum disease and reduced saliva. Rather than pinning it on individuals as etiquette, regular dental visits and oral care matter. Breath care is less about manners than an entry point to preventive medicine.
“座りすぎ”の社会的損失と予防投資
The economic burden tied to sitting eight or more hours a day is estimated at ¥282.5 billion annually. Sedentary behavior is not just a personal habit but a societal cost — calling for prevention designed into workplaces and daily life.